1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with warfarin in 11 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, SC; Huang, TF; Li, HL; Teng, CM; Wu, TS | 1 |
| Hartnell, A; Kay, AB; Moqbel, R | 1 |
| Takahashi, O | 1 |
| Hayakawa, T; Mita, H; Shida, T; Yasueda, H | 1 |
| Dejana, E; Prosdocimi, M; Zanetti, A; Zatta, A | 1 |
| Fukaya, H; Kasama, T; Mayuzumi, K; Ohno, T; Takeuchi, N; Tamaru, K; Tobinaga, S | 1 |
| de Gaetano, G; Dejana, E; Finesso, M; Gorio, A; Languino, LR; Prosdocimi, M; Tessari, F | 1 |
| Aida, Y; Kasama, T; Takeuchi, N; Tobinaga, S | 1 |
| Hsiao, G; Jong, TT; Ko, FN; Teng, CM | 1 |
| Chen, IS; Ishikawa, T; Teng, CM; Tsai, IL; Wun, MF | 1 |
| Chang, FR; Chen, KS; Chia, YC; Chiang, MY; Lan, YH; Wang, JC; Wu, CC; Wu, YC | 1 |
11 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and warfarin
| Article | Year |
|---|---|
Antiplatelet actions of some coumarin compounds isolated from plant sources.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arachidonic Acid; Blood Platelets; Coumarins; Membrane Lipids; Molecular Structure; Phospholipids; Plants; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rabbits; Thrombin; Thromboxane B2 | 1992 |
The effects of picumast on human eosinophil and neutrophil activation.
Topics: Animals; Cell Adhesion; Complement C3b; Coumarins; Cytokines; Eosinophils; Flow Cytometry; Histamine H1 Antagonists; Humans; Immunoglobulin A; Macrophage-1 Antigen; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Rosette Formation; Schistosoma; Up-Regulation | 1991 |
Some properties of rat platelet aggregation and effects of butylated hydroxytoluene, warfarin and aspirin.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Coagulation Factors; Butylated Hydroxytoluene; Collagen; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Inbred Strains; Ristocetin; Warfarin | 1991 |
Quantitation of platelet-activating factor by high-performance liquid chromatography with fluorescent detection.
Topics: Acetyltransferases; Chromatography, High Pressure Liquid; Coumarins; Humans; Hydrolysis; Neutrophils; Platelet Activating Factor; Spectrometry, Fluorescence | 1989 |
The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Aspirin; beta-Thromboglobulin; Blood Platelets; Chromonar; Coumarins; Drug Interactions; Epinephrine; Humans; In Vitro Techniques; Masoprocol; Platelet Activating Factor; Platelet Aggregation; Pyrazoles | 1986 |
The antagonist effects of compounds derived from khellactone on platelet-activating factor.
Topics: Animals; Coumarins; In Vitro Techniques; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Structure-Activity Relationship | 1988 |
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Chromonar; Collagen; Coronary Disease; Coumarins; Disease Models, Animal; Dogs; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Thromboxane B2 | 1985 |
The antagonistic effects of khellactones on platelet-activating factor, histamine, and leukotriene D4.
Topics: Animals; Coumarins; Drug Interactions; Guinea Pigs; Histamine; Histamine Antagonists; Ileum; In Vitro Techniques; Lactones; Leukotriene D4; Male; Mice; Mice, Inbred Strains; Muscle Contraction; Muscle, Smooth; Plant Extracts; Plant Roots; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Wistar; Structure-Activity Relationship | 1995 |
Antiplatelet action of 3',4'-diisovalerylkhellactone diester purified from Peucedanum japonicum Thunb.
Topics: Adenosine Triphosphate; Animals; Apiaceae; Blood Platelets; Calcium; Coumarins; In Vitro Techniques; Phosphatidylinositols; Plant Roots; Plants, Medicinal; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandins; Rabbits; Thromboxane B2 | 1998 |
Anti-platelet aggregation constituents from Formosan Toddalia asiatica.
Topics: Adenosine Diphosphate; Alkaloids; Arachidonic Acid; Benzoquinones; Blood Platelets; Collagen; Coumarins; Humans; Molecular Structure; Plant Extracts; Plant Stems; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Taiwan; Thrombin | 1998 |
Antiplatelet aggregation coumarins from the leaves of Murraya omphalocarpa.
Topics: Animals; Arachidonic Acid; Blood Platelets; Collagen; Coumarins; Models, Molecular; Murraya; Plant Leaves; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Thrombin; X-Ray Diffraction | 2008 |